Lupin P/B Ratio
LUPIN • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
5.01
High Valuation
Very High - Significant premium, high growth expectations or speculative
Current Valuation Metrics
P/B Ratio
5.01
Current Price
₹2190.90
Book Value/Share
₹1900.44
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹17,294 Cr
Share Capital
₹91 Cr
Reserves & Surplus
₹17,112 Cr
Outstanding Shares
91,000,000
Book Value per Share
₹1900.44
Valuation Signal
Signal
Overvalued
Historical Avg
0.95
Historical Range
0.55 - 1.49
Percentile
100.0%
Sector Context
Sector Average
-0.1
Sector Median
0.66
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Lupin
- Stock appears overvalued with PB of 5.01, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 429.6% above historical average
- Trading at premium to sector average PB of -0.1
View the current stock price of Lupin for more insights.
P/B Ratio Historical Trend for Lupin
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Lupin
Additional stock information and data for LUPIN
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.11 | ₹1900.44 | ₹2109.50 | ₹17,294 | Moderate |
| 2024 | 1.49 | ₹1579.56 | ₹2355.70 | ₹14,374 | Moderate |
| 2023 | 0.96 | ₹1378.35 | ₹1322.95 | ₹12,543 | Low |
| 2022 | 0.55 | ₹1343.08 | ₹733.70 | ₹12,222 | Low |
| 2021 | 0.62 | ₹1522.86 | ₹950.75 | ₹13,858 | Low |
Sector P/B Ratio Comparison
Comparing Lupin with other companies in Healthcare sector
Sector Average
-0.1
Sector Median
0.66
Lowest P/B
-12.97
Highest P/B
1.2
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.97 | ₹4,391 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |
| Murae Organisor | MURAE | 0.27 | ₹57 | Low |